About this podcast
Hims House is the ultimate podcast for Hims & Hers investors. Hosted by Jonathan Stern and Patrick Lester, Hims House breaks down all the key questions shaping $HIMS — from telehealth and pharma to GLP-1s, compounding, and the future of healthcare. New episodes every week. <br/><br/><a href="https://himshouse.substack.com?utm_medium=podcast">himshouse.substack.com</a>
79 episodes · Investeren
Hims House
About this podcast
Hims House is the ultimate podcast for Hims & Hers investors. Hosted by Jonathan Stern and Patrick Lester, Hims House breaks down all the key questions shaping $HIMS — from telehealth and pharma to GLP-1s, compounding, and the future of healthcare. New episodes every week. <br/><br/><a href="https://himshouse.substack.com?utm_medium=podcast">himshouse.substack.com</a>
Recent episodes
- Brazil's 2nd-largest telehealth CEO on how Hims & Hers should enter Brazil 🇧🇷8 Oct · 52 min
- Finnrick CEO on gray market peptides, fake bodega vials, and China's manufacturing prowess1 Oct · 40 min
- OpenLoop CEO: the peptide gray market is 2-3x bigger than analyst estimates, likely $6-8 billion16 Sept · 30 min
- HIMS stock token hit $132 on Robinhood over the weekend due to ... $BONER coin?! 😳3 Sept · 39 min
- 🚨 THE FTC SUES HIMS & HERS -- Full breakdown with Gaston Kroub2 Sept · 54 min
- Bijan Salehizadeh - Eli Lilly's War on Compounded GLP-1s, Peptides, Retatrutide, and Hims vs Ro26 Aug · 1 h 00 min
- Enhanced Group CEO: Hot peptide summer is coming — but likely not till 20277 Aug · 54 min
- 🚨 FDA committee votes "YES" on 6 of 7 peptides — here's what happens next, with Dr. Alex Tatem27 Jul · 1 h 00 min
- The FDA peptides vote is days away. This insider expects approval15 Jul · 1 h 01 min
- Ryan MacDonald: Peptides could be a $30B+ market, and Hims is positioned to win meaningful share7 Jul · 1 h 01 min
sharemy.show/en/hims-house
For a poster or slide.